Erratum: Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: Regional differences (Journal of Neuroscience Methods (2004) 140 (133-139) PII: S0165-0270(04)00290-0 and DOI: 10.1016/j.jneumeth.2004.03.028);Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: Regional differences

Journal of Neuroscience Methods

Volumn 140, Issue 1-2 SPEC. ISS., 2004, Pages 133-139

  Lifschytz, Tzuri ^a   Gur, Eitan ^a   Lerer, Bernard ^a   Newman, Michael E ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Antidepressant; Fluoxetine; Microdialysis; Serotonin; Triiodothyronine

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AUTORECEPTOR; FLUOXETINE; LIOTHYRONINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR;

BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DESENSITIZATION; DRUG EFFECT; FRONTAL CORTEX; HYPOTHALAMUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC TRANSMISSION;

EID: 10344237049     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2004.12.008     Document Type: Erratum

References (41)

1. O. Agid, and B. Lerer Algorithm based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation Int. J. Neuropsychopharmacol. 6 2003 41 49
2. L.L. Altshuler, M. Bauer, M.A. Frye, M.J. Gitlin, J. Mintz, M.P. Szuba, K.L. Leight, and P.C. Whybrow Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature Amer. J. Psychiatry 158 2001 1617 1622
3. R. Aronson, H.J. Offman, R.T. Joffe, and D. Naylor Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis Arch. Gen. Psychiatry 53 1996 842 848
4. M. Bauer, A. Heinz, and P.C. Whybrow Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain Mol. Psychiatry. 7 2002 140 156
5. M. Bauer, and P.C. Whybrow Thyroid hormone, neural tissue and mood modulation World J. Biol. Psychiatry. 2 2001 57 67
6. P.B.F. Bergqvist, C. Bouchard, and P. Blier Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder Biol. Psychiat. 45 1999 164 174
7. P. Blier, Y.J. Chaput, and C. de Montigny Long-term 5-HT uptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain Naunyn-Schmiedeberg's Arch. Pharmacol. 337 1988 246 254
8. P. Blier, and C. de Montigny Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat J. Neurosci. 3 1983 1270 1278
9. P. Blier, and C. de Montigny Current advances and trends in the treatment of depression Trends Pharmacol. Sci. 15 1994 220 226
10. P. Blier, and C. de Montigny Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses Biol. Psychiatry. 44 1998 313 323
11. Y. Chaput, C. de Montigny, and P. Blier Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors Naunyn. Schmiedebergs Arch. Pharmacol. 333 1986 342 348
12. Y. Chaput, C. de Montigny, and P. Blier Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments: an in vivo electrophysiological study in the rat Neuropsychopharmacology 5 1991 219 229
13. A.J. Cleare, A. McGregor, and V. O'Keane Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression Clin. Endocrinol. 43 1995 713 719
14. A.J. Cleare, A. McGregor, S.M. Chambers, S. Dawling, and V. O'Keane Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism Neuroendocrinology 64 1996 65 69
15. J.F. Czachura, and K. Rasmussen Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 2000 266 275
16. L.A. Dawson, H.Q. Nguyen, D.I. Smith, and L.E. Schechter Effects of chronic fluoxetine treatment in the presence and absence of (±)-pindolol: a microdialysis study Br. J. Pharmacol. 130 2000 797 804
17. L.A. Dawson, H.Q. Nguyen, D.I. Smith, and L.E. Schechter Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex J. Psychopharmacol. 16 2002 145 152
18. E. Dremencov, E. Gur, B. Lerer, and M.E. Newman Subchronic fluoxetine administration to rats: effects on 5-HT autoreceptor activity as measured by in vivo microdialysis Eur. Neuropsychopharmacol. 10 2000 229 236
19. E. Dremencov, E. Gur, B. Lerer, and M.E. Newman Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus Prog. Neuropsychopharmacol. Biol. Psychiat. 26 2002 1029 1034
20. M.C. Farach-Carson, and P.J. Davis Steroid hormone interactions with target cells: cross-talk between membrane and nuclear pathways J. Pharmacol. Exp. Ther. 307 2003 839 845
21. S. Gupta, P. Masand, and J.F. Tanquary Thyroid hormone supplementation of fluoxetine in the treatment of major depression Brit. J. Psychiatry. 159 1991 866 867
22. E. Gur, B. Lerer, and M.E. Newman Chronic clomipramine and triiodothyronine increase 5-HT levels in rat frontal cortex in vivo: relationship to 5-HT autoreceptor activity J. Pharmacol. Exp. Ther. 288 1999 81 87
23. E. Gur, B. Lerer, E. Dremencov, and M.E. Newman Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain Neuroreport 11 2000 2925 2929
24. E. Gur, T. Lifschytz, B. Lerer, and M.E. Newman Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT1 autoreceptor activity in rat cortex Eur. J. Pharmacol. 457 2002 37 43
25. E. Gur, E. Dremencov, L.D. Van de Kar, B. Lerer, and M.E. Newman Effects of chronically administered venlafaxine on serotonin receptor activity in rat hippocampus and hypothalamus Eur. J. Pharmacol. 436 2002 57 65
26. E. Gur, T. Lifschytz, L.D. Van de Kar, B. Lerer, and M.E. Newman Effects of triiodothyronine on 5-HT1A and 5-HT1B autoreceptor activity, and postsynaptic 5-HT1A receptor activity in rat hypothalamus: lack of interaction with imipramine Psychoneuroendocrinology 29 2004 1172 1183
27. 1A receptor function in brain following agonist or antidepressant administration Life Sci. 72 2003 1665 1682
28. 1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex Pharmacol. Biochem. Behav. 54 1996 143 147
29. R.T. Joffe Triiodothyronine potentiation of fluoxetine in depressed patients Can. J. Psychiatry. 37 1992 48 50
30. D.S. Kreiss, and I. Lucki Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-HT measured in vivo J. Pharmacol. Exp. Ther. 274 1995 866 876
31. 1A autoreceptors in rats treated with fluoxetine or paroxetine Naunyn-Schmiedeberg's Arch. Pharmacol. 352 1995 141 148
32. 1B receptors and 5-HT transporter in rats chronically treated with fluoxetine Neuropharmacology 39 2000 110 122
33. 1B/1D receptors in psychiatric disorders and their potential as a target for therapy Eur. J. Pharmacol. 404 2000 1 12
34. M.E. Newman, B. Shapira, and B. Lerer Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review Int. J. Neuropsychopharmacol. 1 1998 49 69
35. M.E. Newman, O. Agid, E. Gur, and B. Lerer Pharmacological mechanisms of T3 augmentation of antidepressant action Int. J. Neuropsychopharmacol. 3 2000 187 191
36. 1A receptor sensitivity in rat hypothalamus and hippocampus respectively Neuropharmacology 39 2000 2309 2317
37. G. Pineyro, and P. Blier Autoregulation of serotonergic neurons: role in antidepressant drug action Pharmacol. Rev. 51 1999 533 591
38. A.J. Prange Novel uses of thyroid hormones in patients with affective disorders Thyroid 6 1996 537 543
39. J.J. Rutter, C. Gundlah, and S.B. Auerbach Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine Neurosci. Lett. 171 1994 183 186
40. 1B autoreceptor function in the anterior hypothalamus in vivo: effect of chronic antidepressant treatment Br. J. Pharmacol. 126 1999 1777 1784
41. D.F. Swaab, E. Fliers, Hoogendijk WJG, D.J. Veltman, and J.N. Zhou Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression Prog. Brain Res. 126 2000 369 396